Published in Blood Weekly, October 16th, 2008
"The authors investigated the efficacy and safety of low-dose IL-11 for improving thrombocytopenia associated with TKI...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.